Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Plos One|January 25, 2023
Diagnostic accuracy of the Panbio COVID-19 antigen rapid test device for SARS-CoV-2 detection in Kenya, 2021: A field evaluationJack Karuga Irungu, Peninah Munyua, Caroline Ochieng, et al.
Vaccine|December 17, 2023
Comparing performance of year-round and campaign-mode influenza vaccination strategies among children aged 6-23 months in Kenya: 2019-2021Jeanette Dawa, Rose Jalang'o, Harriet Mirieri, et al.
BMJ Global Health|August 1, 2022
Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in KenyaStacey Orangi, John Ojal, Samuel Pc Brand, et al.
Wellcome Open Research|December 14, 2022
Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test dataJohn Ojal, Samuel P C Brand, Vincent Were, et al.
Nature Communications|June 26, 2021
Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in KenyaIfedayo M O Adetifa, Sophie Uyoga, John N Gitonga, et al.
Science (New York, N.Y.)|October 7, 2021
COVID-19 transmission dynamics underlying epidemic waves in KenyaSamuel P C Brand, John Ojal, Rabia Aziza, et al.
Vaccine|May 13, 2025
Factors associated with laboratory-confirmed SARS-Cov-2 infection among patients with severe respiratory illness (SRI): Findings from the COVID-19 vaccine effectiveness evaluation in Kenya and Mali, 2022-2023Raphael O Anyango, Bryan O Nyawanda, Brian O Onyando, et al.
Vaccine|March 2, 2025
Factors associated with mortality among patients aged 12 years and above requiring hospitalization for severe respiratory illness (SRI): Findings from the COVID-19 vaccine effectiveness evaluation in Kenya and Mali, 2022-2023Brian O Onyando, Bryan O Nyawanda, Daniel Onguru, et al.
Elife|June 14, 2022
Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: A retrospective genomic studyCharles N Agoti, Lynette Isabella Ochola-Oyier, Simon Dellicour, et al.
Influenza and Other Respiratory Viruses|September 26, 2023
SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022E Wangeci Kagucia, Abdhala K Ziraba, James Nyagwange, et al.
Pageof 4